_id
6919f13d3c536f8df23185d9
Ticker
4AB.XETRA
Name
AbbVie Inc
Exchange
XETRA
Address
1 North Waukegan Road, North Chicago, IL, United States, 60064-6400
Country
Germany
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
EUR
Website
https://www.abbvie.com
Description
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Last Close
196.8
Volume
119
Current Price
187.6
Change
-0.10162601626017126
Last Updated
2025-12-30T11:50:49.847Z
Image
https://logo.clearbit.com/www.abbvie.com
Ipo Date
-
Market Cap
348116615168
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
15776000000
Cost Of Revenue
3390000000
Gross Profit
12386000000
Operating Expenses
7495000000
Operating Income
4891000000
Interest Expense
667000000
Pretax Income
714000000
Net Income
186000000
Eps
0.10496613995485328
Dividends Per Share
2911000000
Shares Outstanding
1767384632
Income Tax Expense
526000000
EBITDA
3444000000
Operating Margin
31.002789046653145
Total Other Income Expense Net
-4177000000
Cash
5629000000
Short Term Investments
42000000
Receivables
12769000000
Inventories
4938000000
Total Current Assets
28539000000
Property Plant Equipment
5483000000
Total Assets
133898000000
Payables
-
Short Term Debt
5772000000
Long Term Debt
62971000000
Total Liabilities
136497000000
Equity
-2642000000
Bs_currency_symbol
USD
Depreciation
2063000000
Change In Working Capital
3142000000
Cash From Operations
7024000000
Capital Expenditures
504000000
Cash From Investing
-3264000000
Cash From Financing
-4590000000
Net Change In Cash
-838000000
Cf_currency_symbol
USD
PE
175.7143
PB
-125.82407267221802
ROE
-7.040121120363361
ROA
0.13891170891275448
FCF
6520000000
Fcf Percent
0.4132860040567951
Piotroski FScore
3
Health Score
49
Deep Value Investing Score
3
Defensive Investing Score
5
Dividend Investing Score
3.5
Economic Moat Investing Score
6.8
Garp Investing Score
2.5
Growth Investing Score
3
Momentum Investing Score
6
Net Net Investing Score
2
Quality Investing Score
4
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
15776000000
Quarters > 0 > income Statement > cost Of Revenue
3390000000
Quarters > 0 > income Statement > gross Profit
12386000000
Quarters > 0 > income Statement > operating Expenses
7495000000
Quarters > 0 > income Statement > operating Income
4891000000
Quarters > 0 > income Statement > interest Expense
667000000
Quarters > 0 > income Statement > pretax Income
714000000
Quarters > 0 > income Statement > net Income
186000000
Quarters > 0 > income Statement > eps
0.10496613995485328
Quarters > 0 > income Statement > dividends Per Share
2911000000
Quarters > 0 > income Statement > shares Outstanding
1772000000
Quarters > 0 > income Statement > income Tax Expense
526000000
Quarters > 0 > income Statement > EBITDA
3444000000
Quarters > 0 > income Statement > operating Margin
31.002789046653145
Quarters > 0 > income Statement > total Other Income Expense Net
-4177000000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
5629000000
Quarters > 0 > balance Sheet > short Term Investments
42000000
Quarters > 0 > balance Sheet > receivables
12769000000
Quarters > 0 > balance Sheet > inventories
4938000000
Quarters > 0 > balance Sheet > total Current Assets
28539000000
Quarters > 0 > balance Sheet > property Plant Equipment
5483000000
Quarters > 0 > balance Sheet > total Assets
133898000000
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
5772000000
Quarters > 0 > balance Sheet > long Term Debt
62971000000
Quarters > 0 > balance Sheet > total Liabilities
136497000000
Quarters > 0 > balance Sheet > equity
-2642000000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
188000000
Quarters > 0 > cash Flow > depreciation
2063000000
Quarters > 0 > cash Flow > change In Working Capital
3142000000
Quarters > 0 > cash Flow > cash From Operations
7024000000
Quarters > 0 > cash Flow > capital Expenditures
504000000
Quarters > 0 > cash Flow > cash From Investing
-3264000000
Quarters > 0 > cash Flow > cash From Financing
-4590000000
Quarters > 0 > cash Flow > net Change In Cash
-838000000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
0.10496613995485328
Quarters > 0 > ratios > PB
-125.82407267221802
Quarters > 0 > ratios > ROE
-7.040121120363361
Quarters > 0 > ratios > ROA
0.13891170891275448
Quarters > 0 > ratios > FCF
6520000000
Quarters > 0 > ratios > Piotroski FScore
3
Quarters > 0 > ratios > fcf Percent
0.4132860040567951
Quarters > 0 > health Score
49
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
15423000000
Quarters > 1 > income Statement > cost Of Revenue
4346000000
Quarters > 1 > income Statement > gross Profit
11077000000
Quarters > 1 > income Statement > operating Expenses
6183000000
Quarters > 1 > income Statement > operating Income
4894000000
Quarters > 1 > income Statement > interest Expense
740000000
Quarters > 1 > income Statement > pretax Income
1554000000
Quarters > 1 > income Statement > net Income
938000000
Quarters > 1 > income Statement > eps
0.5296442687747036
Quarters > 1 > income Statement > dividends Per Share
2910000000
Quarters > 1 > income Statement > shares Outstanding
1771000000
Quarters > 1 > income Statement > income Tax Expense
613000000
Quarters > 1 > income Statement > EBITDA
4344000000
Quarters > 1 > income Statement > operating Margin
31.731829086429357
Quarters > 1 > income Statement > total Other Income Expense Net
-3340000000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
6467000000
Quarters > 1 > balance Sheet > short Term Investments
0
Quarters > 1 > balance Sheet > receivables
12637000000
Quarters > 1 > balance Sheet > inventories
4960000000
Quarters > 1 > balance Sheet > total Current Assets
29261000000
Quarters > 1 > balance Sheet > property Plant Equipment
5283000000
Quarters > 1 > balance Sheet > total Assets
137182000000
Quarters > 1 > balance Sheet > payables
-
Quarters > 1 > balance Sheet > short Term Debt
7522000000
Quarters > 1 > balance Sheet > long Term Debt
62959000000
Quarters > 1 > balance Sheet > total Liabilities
137320000000
Quarters > 1 > balance Sheet > equity
-183000000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
941000000
Quarters > 1 > cash Flow > depreciation
2050000000
Quarters > 1 > cash Flow > change In Working Capital
-562000000
Quarters > 1 > cash Flow > cash From Operations
5153000000
Quarters > 1 > cash Flow > capital Expenditures
269000000
Quarters > 1 > cash Flow > cash From Investing
-1181000000
Quarters > 1 > cash Flow > cash From Financing
-2710000000
Quarters > 1 > cash Flow > net Change In Cash
1292000000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
0.5296442687747036
Quarters > 1 > ratios > PB
-1815.5169398907103
Quarters > 1 > ratios > ROE
-512.568306010929
Quarters > 1 > ratios > ROA
0.6837631759268709
Quarters > 1 > ratios > FCF
4884000000
Quarters > 1 > ratios > Piotroski FScore
3
Quarters > 1 > ratios > fcf Percent
0.3166699085780976
Quarters > 1 > health Score
50
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
13343000000
Quarters > 2 > income Statement > cost Of Revenue
4002000000
Quarters > 2 > income Statement > gross Profit
9341000000
Quarters > 2 > income Statement > operating Expenses
5608000000
Quarters > 2 > income Statement > operating Income
3733000000
Quarters > 2 > income Statement > interest Expense
700000000
Quarters > 2 > income Statement > pretax Income
1661000000
Quarters > 2 > income Statement > net Income
1286000000
Quarters > 2 > income Statement > eps
0.7257336343115124
Quarters > 2 > income Statement > dividends Per Share
2925000000
Quarters > 2 > income Statement > shares Outstanding
1772000000
Quarters > 2 > income Statement > income Tax Expense
372000000
Quarters > 2 > income Statement > EBITDA
4400000000
Quarters > 2 > income Statement > operating Margin
27.977216518024434
Quarters > 2 > income Statement > total Other Income Expense Net
-2072000000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
5175000000
Quarters > 2 > balance Sheet > short Term Investments
1000000
Quarters > 2 > balance Sheet > receivables
12477000000
Quarters > 2 > balance Sheet > inventories
4526000000
Quarters > 2 > balance Sheet > total Current Assets
27675000000
Quarters > 2 > balance Sheet > property Plant Equipment
5237000000
Quarters > 2 > balance Sheet > total Assets
136165000000
Quarters > 2 > balance Sheet > payables
30714000000
Quarters > 2 > balance Sheet > short Term Debt
5362000000
Quarters > 2 > balance Sheet > long Term Debt
64527000000
Quarters > 2 > balance Sheet > total Liabilities
134703000000
Quarters > 2 > balance Sheet > equity
1420000000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
1289000000
Quarters > 2 > cash Flow > depreciation
2039000000
Quarters > 2 > cash Flow > change In Working Capital
-2580000000
Quarters > 2 > cash Flow > cash From Operations
1635000000
Quarters > 2 > cash Flow > capital Expenditures
235000000
Quarters > 2 > cash Flow > cash From Investing
-735000000
Quarters > 2 > cash Flow > cash From Financing
-1258000000
Quarters > 2 > cash Flow > net Change In Cash
-349000000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
0.7257336343115124
Quarters > 2 > ratios > PB
234.103661971831
Quarters > 2 > ratios > ROE
90.56338028169014
Quarters > 2 > ratios > ROA
0.9444424044357947
Quarters > 2 > ratios > FCF
1400000000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.10492393015064079
Quarters > 2 > health Score
50
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
15102000000
Quarters > 3 > income Statement > cost Of Revenue
4396000000
Quarters > 3 > income Statement > gross Profit
10706000000
Quarters > 3 > income Statement > operating Expenses
12196000000
Quarters > 3 > income Statement > operating Income
-1490000000
Quarters > 3 > income Statement > interest Expense
702000000
Quarters > 3 > income Statement > pretax Income
-2269000000
Quarters > 3 > income Statement > net Income
-22000000
Quarters > 3 > income Statement > eps
-0.01243640474844545
Quarters > 3 > income Statement > dividends Per Share
2752000000
Quarters > 3 > income Statement > shares Outstanding
1769000000
Quarters > 3 > income Statement > income Tax Expense
-2246000000
Quarters > 3 > income Statement > EBITDA
535000000
Quarters > 3 > income Statement > operating Margin
-9.866242881737518
Quarters > 3 > income Statement > total Other Income Expense Net
-779000000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
5524000000
Quarters > 3 > balance Sheet > short Term Investments
31000000
Quarters > 3 > balance Sheet > receivables
10919000000
Quarters > 3 > balance Sheet > inventories
4181000000
Quarters > 3 > balance Sheet > total Current Assets
25582000000
Quarters > 3 > balance Sheet > property Plant Equipment
5134000000
Quarters > 3 > balance Sheet > total Assets
135161000000
Quarters > 3 > balance Sheet > payables
2945000000
Quarters > 3 > balance Sheet > short Term Debt
6804000000
Quarters > 3 > balance Sheet > long Term Debt
60340000000
Quarters > 3 > balance Sheet > total Liabilities
131797000000
Quarters > 3 > balance Sheet > equity
3325000000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-23000000
Quarters > 3 > cash Flow > depreciation
2102000000
Quarters > 3 > cash Flow > change In Working Capital
-397000000
Quarters > 3 > cash Flow > cash From Operations
7048000000
Quarters > 3 > cash Flow > capital Expenditures
291000000
Quarters > 3 > cash Flow > cash From Investing
-1874000000
Quarters > 3 > cash Flow > cash From Financing
-6861000000
Quarters > 3 > cash Flow > net Change In Cash
-1733000000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.01243640474844545
Quarters > 3 > ratios > PB
99.80884210526315
Quarters > 3 > ratios > ROE
-0.6616541353383459
Quarters > 3 > ratios > ROA
-0.01627688460428674
Quarters > 3 > ratios > FCF
6757000000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.4474241822275195
Quarters > 3 > health Score
28
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
56334000000
Annuals > 0 > income Statement > cost Of Revenue
16904000000
Annuals > 0 > income Statement > gross Profit
39430000000
Annuals > 0 > income Statement > operating Expenses
30293000000
Annuals > 0 > income Statement > operating Income
9137000000
Annuals > 0 > income Statement > interest Expense
2808000000
Annuals > 0 > income Statement > pretax Income
3716000000
Annuals > 0 > income Statement > net Income
4278000000
Annuals > 0 > income Statement > eps
2.412859560067682
Annuals > 0 > income Statement > dividends Per Share
11025000000
Annuals > 0 > income Statement > shares Outstanding
1773000000
Annuals > 0 > income Statement > income Tax Expense
-570000000
Annuals > 0 > income Statement > EBITDA
14910000000
Annuals > 0 > income Statement > operating Margin
16.219334682429793
Annuals > 0 > income Statement > total Other Income Expense Net
-5421000000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
5524000000
Annuals > 0 > balance Sheet > short Term Investments
31000000
Annuals > 0 > balance Sheet > receivables
10919000000
Annuals > 0 > balance Sheet > inventories
4181000000
Annuals > 0 > balance Sheet > total Current Assets
25582000000
Annuals > 0 > balance Sheet > property Plant Equipment
5134000000
Annuals > 0 > balance Sheet > total Assets
135161000000
Annuals > 0 > balance Sheet > payables
2945000000
Annuals > 0 > balance Sheet > short Term Debt
6804000000
Annuals > 0 > balance Sheet > long Term Debt
60340000000
Annuals > 0 > balance Sheet > total Liabilities
131797000000
Annuals > 0 > balance Sheet > equity
3325000000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
4286000000
Annuals > 0 > cash Flow > depreciation
8386000000
Annuals > 0 > cash Flow > change In Working Capital
-2782000000
Annuals > 0 > cash Flow > cash From Operations
18806000000
Annuals > 0 > cash Flow > capital Expenditures
974000000
Annuals > 0 > cash Flow > cash From Investing
-20820000000
Annuals > 0 > cash Flow > cash From Financing
-5211000000
Annuals > 0 > cash Flow > net Change In Cash
-7290000000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
2.412859560067682
Annuals > 0 > ratios > PB
105.15356390977443
Annuals > 0 > ratios > ROE
128.66165413533835
Annuals > 0 > ratios > ROA
3.165114197142667
Annuals > 0 > ratios > FCF
17832000000
Annuals > 0 > ratios > Piotroski FScore
3
Annuals > 0 > ratios > fcf Percent
0.31654063265523485
Annuals > 0 > health Score
60
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
54318000000
Annuals > 1 > income Statement > cost Of Revenue
16726000000
Annuals > 1 > income Statement > gross Profit
37592000000
Annuals > 1 > income Statement > operating Expenses
24835000000
Annuals > 1 > income Statement > operating Income
12757000000
Annuals > 1 > income Statement > interest Expense
2224000000
Annuals > 1 > income Statement > pretax Income
6250000000
Annuals > 1 > income Statement > net Income
4863000000
Annuals > 1 > income Statement > eps
2.742808798646362
Annuals > 1 > income Statement > dividends Per Share
10539000000
Annuals > 1 > income Statement > shares Outstanding
1773000000
Annuals > 1 > income Statement > income Tax Expense
1377000000
Annuals > 1 > income Statement > EBITDA
17172000000
Annuals > 1 > income Statement > operating Margin
23.485768990021725
Annuals > 1 > income Statement > total Other Income Expense Net
-6507000000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
12814000000
Annuals > 1 > balance Sheet > short Term Investments
2000000
Annuals > 1 > balance Sheet > receivables
11155000000
Annuals > 1 > balance Sheet > inventories
4099000000
Annuals > 1 > balance Sheet > total Current Assets
33002000000
Annuals > 1 > balance Sheet > property Plant Equipment
5733000000
Annuals > 1 > balance Sheet > total Assets
134711000000
Annuals > 1 > balance Sheet > payables
3688000000
Annuals > 1 > balance Sheet > short Term Debt
7357000000
Annuals > 1 > balance Sheet > long Term Debt
52194000000
Annuals > 1 > balance Sheet > total Liabilities
124314000000
Annuals > 1 > balance Sheet > equity
10360000000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
4873000000
Annuals > 1 > cash Flow > depreciation
8698000000
Annuals > 1 > cash Flow > change In Working Capital
2813000000
Annuals > 1 > cash Flow > cash From Operations
22839000000
Annuals > 1 > cash Flow > capital Expenditures
777000000
Annuals > 1 > cash Flow > cash From Investing
-2009000000
Annuals > 1 > cash Flow > cash From Financing
-17222000000
Annuals > 1 > cash Flow > net Change In Cash
3613000000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
2.742808798646362
Annuals > 1 > ratios > PB
33.74861003861004
Annuals > 1 > ratios > ROE
46.940154440154444
Annuals > 1 > ratios > ROA
3.6099501896652835
Annuals > 1 > ratios > FCF
22062000000
Annuals > 1 > ratios > Piotroski FScore
3
Annuals > 1 > ratios > fcf Percent
0.40616370264000884
Annuals > 1 > health Score
61
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
58054000000
Annuals > 2 > income Statement > cost Of Revenue
17414000000
Annuals > 2 > income Statement > gross Profit
40640000000
Annuals > 2 > income Statement > operating Expenses
21826000000
Annuals > 2 > income Statement > operating Income
11192000000
Annuals > 2 > income Statement > interest Expense
2230000000
Annuals > 2 > income Statement > pretax Income
13477000000
Annuals > 2 > income Statement > net Income
11836000000
Annuals > 2 > income Statement > eps
6.656917885264342
Annuals > 2 > income Statement > dividends Per Share
10043000000
Annuals > 2 > income Statement > shares Outstanding
1778000000
Annuals > 2 > income Statement > income Tax Expense
1632000000
Annuals > 2 > income Statement > EBITDA
24174000000
Annuals > 2 > income Statement > operating Margin
19.278602680263205
Annuals > 2 > income Statement > total Other Income Expense Net
2285000000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
9201000000
Annuals > 2 > balance Sheet > short Term Investments
28000000
Annuals > 2 > balance Sheet > receivables
11254000000
Annuals > 2 > balance Sheet > inventories
3579000000
Annuals > 2 > balance Sheet > total Current Assets
28463000000
Annuals > 2 > balance Sheet > property Plant Equipment
4935000000
Annuals > 2 > balance Sheet > total Assets
138805000000
Annuals > 2 > balance Sheet > payables
2934000000
Annuals > 2 > balance Sheet > short Term Debt
4319000000
Annuals > 2 > balance Sheet > long Term Debt
59135000000
Annuals > 2 > balance Sheet > total Liabilities
121518000000
Annuals > 2 > balance Sheet > equity
17254000000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
11845000000
Annuals > 2 > cash Flow > depreciation
8467000000
Annuals > 2 > cash Flow > change In Working Capital
-258000000
Annuals > 2 > cash Flow > cash From Operations
24943000000
Annuals > 2 > cash Flow > capital Expenditures
695000000
Annuals > 2 > cash Flow > cash From Investing
-623000000
Annuals > 2 > cash Flow > cash From Financing
-24803000000
Annuals > 2 > cash Flow > net Change In Cash
-545000000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
6.656917885264342
Annuals > 2 > ratios > PB
20.32117769792512
Annuals > 2 > ratios > ROE
68.59858583516866
Annuals > 2 > ratios > ROA
8.527070350491698
Annuals > 2 > ratios > FCF
24248000000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.41768009094980535
Annuals > 2 > health Score
67
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
56197000000
Annuals > 3 > income Statement > cost Of Revenue
17446000000
Annuals > 3 > income Statement > gross Profit
38751000000
Annuals > 3 > income Statement > operating Expenses
19865000000
Annuals > 3 > income Statement > operating Income
7865000000
Annuals > 3 > income Statement > interest Expense
2423000000
Annuals > 3 > income Statement > pretax Income
12989000000
Annuals > 3 > income Statement > net Income
11542000000
Annuals > 3 > income Statement > eps
6.495216657287563
Annuals > 3 > income Statement > dividends Per Share
9261000000
Annuals > 3 > income Statement > shares Outstanding
1777000000
Annuals > 3 > income Statement > income Tax Expense
1440000000
Annuals > 3 > income Statement > EBITDA
23933000000
Annuals > 3 > income Statement > operating Margin
13.99540900759827
Annuals > 3 > income Statement > total Other Income Expense Net
5124000000
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
9746000000
Annuals > 3 > balance Sheet > short Term Investments
84000000
Annuals > 3 > balance Sheet > receivables
9977000000
Annuals > 3 > balance Sheet > inventories
3128000000
Annuals > 3 > balance Sheet > total Current Assets
27928000000
Annuals > 3 > balance Sheet > property Plant Equipment
5110000000
Annuals > 3 > balance Sheet > total Assets
146529000000
Annuals > 3 > balance Sheet > payables
2882000000
Annuals > 3 > balance Sheet > short Term Debt
12495000000
Annuals > 3 > balance Sheet > long Term Debt
64164000000
Annuals > 3 > balance Sheet > total Liabilities
131093000000
Annuals > 3 > balance Sheet > equity
15408000000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
11549000000
Annuals > 3 > cash Flow > depreciation
8521000000
Annuals > 3 > cash Flow > change In Working Capital
-1322000000
Annuals > 3 > cash Flow > cash From Operations
22777000000
Annuals > 3 > cash Flow > capital Expenditures
787000000
Annuals > 3 > cash Flow > cash From Investing
-2344000000
Annuals > 3 > cash Flow > cash From Financing
-19039000000
Annuals > 3 > cash Flow > net Change In Cash
1297000000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
6.495216657287563
Annuals > 3 > ratios > PB
22.74301661474559
Annuals > 3 > ratios > ROE
74.90913811007269
Annuals > 3 > ratios > ROA
7.8769390359587526
Annuals > 3 > ratios > FCF
21990000000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.39130202679858356
Annuals > 3 > health Score
66
Valuation > metrics > PE
175.7143
Valuation > metrics > PB
-125.82407267221802
Valuation > final Score
20
Valuation > verdict
602.9% Overvalued
Profitability > metrics > ROE
-7.040121120363361
Profitability > metrics > ROA
0.6517397245874067
Profitability > metrics > Net Margin
0.011790060851926978
Profitability > final Score
4
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
7.332833583208396
Risk > final Score
59
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.9443866943866945
Liquidity > metrics > Quick Ratio
4.088877338877339
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
40
Prev Valuations > 2
20
Prev Profitabilities > 0
19
Prev Profitabilities > 1
68
Prev Profitabilities > 2
0
Prev Risks > 0
56
Prev Risks > 1
27
Prev Risks > 2
-2
Prev Liquidities > 0
100
Prev Liquidities > 1
42
Prev Liquidities > 2
100
Updated At
2026-01-20T23:05:14.108Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-04-23
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-12-31
Earnings History > 1 > report Date
2026-02-06
Earnings History > 1 > date
2025-12-31
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-
Earnings History > 1 > eps Estimate
3.35
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-09-30
Earnings History > 2 > report Date
2025-10-31
Earnings History > 2 > date
2025-09-30
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.085
Earnings History > 2 > eps Estimate
1.78
Earnings History > 2 > eps Difference
-1.695
Earnings History > 2 > surprise Percent
-95.2247
Earnings History > 3 > period
2025-06-30
Earnings History > 3 > report Date
2025-07-31
Earnings History > 3 > date
2025-06-30
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
EUR
Earnings History > 3 > eps Actual
0.4619
Earnings History > 3 > eps Estimate
2.91
Earnings History > 3 > eps Difference
-2.4481
Earnings History > 3 > surprise Percent
-84.1271
Earnings History > 4 > period
2025-03-31
Earnings History > 4 > report Date
2025-04-25
Earnings History > 4 > date
2025-03-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
EUR
Earnings History > 4 > eps Actual
0.6896
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-12-31
Earnings History > 5 > report Date
2025-01-31
Earnings History > 5 > date
2024-12-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
EUR
Earnings History > 5 > eps Actual
-0.0117
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-09-30
Earnings History > 6 > report Date
2024-10-30
Earnings History > 6 > date
2024-09-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
0.7968
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-06-30
Earnings History > 7 > report Date
2024-07-25
Earnings History > 7 > date
2024-06-30
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
0.7186
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2024-03-31
Earnings History > 8 > report Date
2024-04-26
Earnings History > 8 > date
2024-03-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
0.7114
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-12-31
Earnings History > 9 > report Date
2024-03-14
Earnings History > 9 > date
2023-12-31
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
0.4314
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-09-30
Earnings History > 10 > report Date
2023-10-27
Earnings History > 10 > date
2023-09-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
0.9229
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-06-30
Earnings History > 11 > report Date
2023-07-27
Earnings History > 11 > date
2023-06-30
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
1.0501
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2023-03-31
Earnings History > 12 > report Date
2023-04-27
Earnings History > 12 > date
2023-03-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
0.1254
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-12-31
Earnings History > 13 > report Date
2023-02-09
Earnings History > 13 > date
2022-12-31
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
1.3635
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-09-30
Earnings History > 14 > report Date
2022-10-28
Earnings History > 14 > date
2022-09-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
2.2087
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2022-06-30
Earnings History > 15 > report Date
2022-07-29
Earnings History > 15 > date
2022-06-30
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
EUR
Earnings History > 15 > eps Actual
0.4889
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2022-03-31
Earnings History > 16 > report Date
2022-04-29
Earnings History > 16 > date
2022-03-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
EUR
Earnings History > 16 > eps Actual
2.2511
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-12-31
Earnings History > 17 > report Date
2022-02-02
Earnings History > 17 > date
2021-12-31
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
EUR
Earnings History > 17 > eps Actual
1.9899
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-09-30
Earnings History > 18 > report Date
2021-10-29
Earnings History > 18 > date
2021-09-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
EUR
Earnings History > 18 > eps Actual
1.5177
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2021-06-30
Earnings History > 19 > report Date
2021-07-30
Earnings History > 19 > date
2021-06-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
EUR
Earnings History > 19 > eps Actual
0.3498
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2021-03-31
Earnings History > 20 > report Date
2021-04-30
Earnings History > 20 > date
2021-03-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
EUR
Earnings History > 20 > eps Actual
1.6619
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-12-31
Earnings History > 21 > report Date
2021-02-03
Earnings History > 21 > date
2020-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
EUR
Earnings History > 21 > eps Actual
0.0094
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-09-30
Earnings History > 22 > report Date
2020-09-30
Earnings History > 22 > date
2020-09-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
EUR
Earnings History > 22 > eps Actual
1.1049
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2020-06-30
Earnings History > 23 > report Date
2020-06-30
Earnings History > 23 > date
2020-06-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
EUR
Earnings History > 23 > eps Actual
-0.4168
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2020-03-31
Earnings History > 24 > report Date
2020-03-31
Earnings History > 24 > date
2020-03-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
EUR
Earnings History > 24 > eps Actual
1.8326
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-12-31
Earnings History > 25 > report Date
2019-12-31
Earnings History > 25 > date
2019-12-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
EUR
Earnings History > 25 > eps Actual
1.6958
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-09-30
Earnings History > 26 > report Date
2019-09-30
Earnings History > 26 > date
2019-09-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
EUR
Earnings History > 26 > eps Actual
1.1365
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2019-06-30
Earnings History > 27 > report Date
2019-06-30
Earnings History > 27 > date
2019-06-30
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
EUR
Earnings History > 27 > eps Actual
0.4396
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2019-03-31
Earnings History > 28 > report Date
2019-03-31
Earnings History > 28 > date
2019-03-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
EUR
Earnings History > 28 > eps Actual
1.4514
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-12-31
Earnings History > 29 > report Date
2018-12-31
Earnings History > 29 > date
2018-12-31
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
EUR
Earnings History > 29 > eps Actual
-1.0779
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2018-09-30
Earnings History > 30 > report Date
2018-09-30
Earnings History > 30 > date
2018-09-30
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
EUR
Earnings History > 30 > eps Actual
1.5521
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2018-06-30
Earnings History > 31 > report Date
2018-06-30
Earnings History > 31 > date
2018-06-30
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
EUR
Earnings History > 31 > eps Actual
1.0539
Earnings History > 31 > eps Estimate
-
Earnings History > 31 > eps Difference
0
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2018-03-31
Earnings History > 32 > report Date
2018-03-31
Earnings History > 32 > date
2018-03-31
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
EUR
Earnings History > 32 > eps Actual
1.4127
Earnings History > 32 > eps Estimate
-
Earnings History > 32 > eps Difference
0
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2017-12-31
Earnings History > 33 > report Date
2017-12-31
Earnings History > 33 > date
2017-12-31
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
EUR
Earnings History > 33 > eps Actual
0.0276
Earnings History > 33 > eps Estimate
-
Earnings History > 33 > eps Difference
0
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2017-09-30
Earnings History > 34 > report Date
2017-09-30
Earnings History > 34 > date
2017-09-30
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
EUR
Earnings History > 34 > eps Actual
0.8619
Earnings History > 34 > eps Estimate
-
Earnings History > 34 > eps Difference
0
Earnings History > 34 > surprise Percent
-
Earnings History > 35 > period
2017-06-30
Earnings History > 35 > report Date
2017-06-30
Earnings History > 35 > date
2017-06-30
Earnings History > 35 > before After Market
-
Earnings History > 35 > currency
EUR
Earnings History > 35 > eps Actual
1.0816
Earnings History > 35 > eps Estimate
-
Earnings History > 35 > eps Difference
0
Earnings History > 35 > surprise Percent
-
Earnings History > 36 > period
2017-03-31
Earnings History > 36 > report Date
2017-03-31
Earnings History > 36 > date
2017-03-31
Earnings History > 36 > before After Market
-
Earnings History > 36 > currency
EUR
Earnings History > 36 > eps Actual
0.9962
Earnings History > 36 > eps Estimate
-
Earnings History > 36 > eps Difference
0
Earnings History > 36 > surprise Percent
-
Earnings History > 37 > period
2016-12-31
Earnings History > 37 > report Date
2016-12-31
Earnings History > 37 > date
2016-12-31
Earnings History > 37 > before After Market
-
Earnings History > 37 > currency
EUR
Earnings History > 37 > eps Actual
0.7913
Earnings History > 37 > eps Estimate
-
Earnings History > 37 > eps Difference
0
Earnings History > 37 > surprise Percent
-
Earnings History > 38 > period
2016-09-30
Earnings History > 38 > report Date
2016-09-30
Earnings History > 38 > date
2016-09-30
Earnings History > 38 > before After Market
-
Earnings History > 38 > currency
EUR
Earnings History > 38 > eps Actual
0.8687
Earnings History > 38 > eps Estimate
-
Earnings History > 38 > eps Difference
0
Earnings History > 38 > surprise Percent
-
Earnings History > 39 > period
2016-06-30
Earnings History > 39 > report Date
2016-06-30
Earnings History > 39 > date
2016-06-30
Earnings History > 39 > before After Market
-
Earnings History > 39 > currency
EUR
Earnings History > 39 > eps Actual
0.8693
Earnings History > 39 > eps Estimate
-
Earnings History > 39 > eps Difference
0
Earnings History > 39 > surprise Percent
-
Earnings History > 40 > period
2016-03-31
Earnings History > 40 > report Date
2016-03-31
Earnings History > 40 > date
2016-03-31
Earnings History > 40 > before After Market
-
Earnings History > 40 > currency
EUR
Earnings History > 40 > eps Actual
0.7519
Earnings History > 40 > eps Estimate
-
Earnings History > 40 > eps Difference
0
Earnings History > 40 > surprise Percent
-
Earnings History > 41 > period
2015-12-31
Earnings History > 41 > report Date
2015-12-31
Earnings History > 41 > date
2015-12-31
Earnings History > 41 > before After Market
-
Earnings History > 41 > currency
EUR
Earnings History > 41 > eps Actual
0.8407
Earnings History > 41 > eps Estimate
-
Earnings History > 41 > eps Difference
0
Earnings History > 41 > surprise Percent
-
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Stock Price
€0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very Low
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of AbbVie Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
3.35
Date
2025-09-30
EPS Actual
0.085
EPS Estimate
1.78
EPS Difference
-1.695
Surprise Percent
-95.2247%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2025-09-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.